Event-free and absolute survival from the date of diagnosis concerning objective 1 and from the date of randomisation concerning objective 2 5 years [clinicaltrials_resource:536317f1423bfe5c0fffe0237f5eeb4d]
Daunoxome, standard risk
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Event-free and absolute survival from the date of diagnosis concerning objective 1 and from the date of randomisation concerning objective 2 5 years [clinicaltrials_resource:536317f1423bfe5c0fffe0237f5eeb4d]
Daunoxome, standard risk
Bio2RDF identifier
536317f1423bfe5c0fffe0237f5eeb4d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:536317f1423bfe5c0fffe0237f5eeb4d
measure [clinicaltrials_vocabulary:measure]
Event-free and absolute surviv ...... isation concerning objective 2
time frame [clinicaltrials_vocabulary:time-frame]
description
Daunoxome, standard risk
identifier
clinicaltrials_resource:536317f1423bfe5c0fffe0237f5eeb4d
title
Event-free and absolute surviv ...... concerning objective 2 5 years
@en
type
label
Event-free and absolute surviv ...... 317f1423bfe5c0fffe0237f5eeb4d]
@en